InsidersTradesSigma
Medicamen Organics: directors' dealings · India · SEBI (PIT + SAST)
Explore the full directors' dealings record of Medicamen Organics, a listed equity based in India. Shares are listed on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €3.5bn. The latest transaction was reported on 19 June 2026 (Acquisition). Among the most active insiders: Pradeep Kumar Jain. Every trade is accessible without an account.
2
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
0 ops.
Sell Volume
5Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 16,523 of 24,974 companies
41.3
score / 100
Value31
Quality52
FCF yld-11%
Earn yld2.8%
EV/EBITDA17.3x
ROE4.0%
Gross mgn49%
Net mgn4.9%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 19 June 2026
Declarations2 total
2,000,000 sharesEquity sharesPreferential AllotmentSEBI:8bc45bc3cad2c47f27d5d6a320e70c9457c4b29a
Ideal exit: 16 Mar 2027 (T+270)
714,285 sharesEquity sharesPreferential AllotmentSEBI:0c3b8e32e4ae77a97e6b86e8eb4959943dafb752
Ideal exit: 16 Mar 2027 (T+270)
2 of 2 declarations
About Medicamen Organics
Medicamen Organics is a company listed on the Bombay Stock Exchange, specializing in the manufacture of pharmaceutical products. It focuses on the development of generic drugs and innovative formulations.